GBP 510
Alternative Names: GBP-510; GSK-4382371A; SKYCovion; SKYCovioneLatest Information Update: 15 Nov 2023
At a glance
- Originator SK Bioscience; University of Washington
- Developer Coalition for Epidemic Preparedness Innovations; GSK; SK Bioscience
- Class COVID-19 vaccines; Subunit vaccines; Synthetic vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Registered COVID 2019 infections
Most Recent Events
- 09 Nov 2023 Immunogenicity data from a phase I/II trial in COVID-2019 infections released by SK Bioscience
- 09 Nov 2023 Safety data from a phase III trial in COVID-2019 infections released by SK Bioscience
- 31 May 2023 Registered for COVID-2019 infections (Prevention, In adults, In the elderly) in United Kingdom (IM)